切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2024, Vol. 14 ›› Issue (06) : 321 -324. doi: 10.3877/cma.j.issn.2095-123X.2024.06.001

述评

脑深部电刺激术在帕金森病中的临床应用与研究进展
孙金兴1, 林豪鹏1, 贾俊恒1, 李珍柯1, 张超1, 吴倩倩1, 李新钢1, 李卫国1,()   
  1. 1.250013 济南,山东大学齐鲁医院神经外科
  • 收稿日期:2024-12-01 出版日期:2024-12-15
  • 通信作者: 李卫国
  • 基金资助:
    山东省重点研发计划(2022ZLGX03)工信部产业技术基础公共服务平台项目(2022189181)十四五国家重点研发计划(2022YFC240510)山东省重大科技创新工程(2022ZLGX03-6)关于应用多模态技术预测帕金森DBS术后效果的研究(6010123074)

Clinical applications and research progress of deep brain stimulation in Parkinson's disease

Jinxing Sun1, Haopeng Lin1, Junheng Jia1, Zhenke Li1, Chao Zhang1, Qianqian Wu1, Xingang Li1, Weiguo Li1,()   

  1. 1.Department of Neurosurgery,Qilu Hospital,Shandong University,Ji'nan 250013,China
  • Received:2024-12-01 Published:2024-12-15
  • Corresponding author: Weiguo Li
引用本文:

孙金兴, 林豪鹏, 贾俊恒, 李珍柯, 张超, 吴倩倩, 李新钢, 李卫国. 脑深部电刺激术在帕金森病中的临床应用与研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(06): 321-324.

Jinxing Sun, Haopeng Lin, Junheng Jia, Zhenke Li, Chao Zhang, Qianqian Wu, Xingang Li, Weiguo Li. Clinical applications and research progress of deep brain stimulation in Parkinson's disease[J/OL]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2024, 14(06): 321-324.

帕金森病(PD)是一种渐进性的神经退行性疾病,具有运动症状和非运动症状。脑深部电刺激术(DBS)适用于药物治疗无法充分控制症状、难以保证良好生活质量的晚期PD 患者,以及因多巴胺能药物产生严重不良反应(如异动症)的患者。DBS可根据患者的具体症状进行个性化治疗,针对基底节-丘脑通路中的不同节点开展治疗,这些节点对疾病的多种症状具有介导作用。丘脑腹中间核DBS 在控制震颤方面的效果最突出,苍白球DBS 在控制僵硬和异动症方面成效显著,而丘脑底核DBS 能够同时对震颤、运动迟缓、僵硬和异动症进行治疗,并且可以减少患者的药物使用量,也是疾病晚期的首选治疗目标。DBS对肢体症状具有长期的治疗效果,但随着疾病的进展,非多巴胺能轴向特征对DBS 的反应会逐渐变差。PD 的DBS 治疗具有很高的专业性,需要由运动障碍神经学家、功能神经外科医生、专业的DBS 程控人员以及神经心理学家组成的多学科团队来对患者进行筛选和随访。本文围绕PD的病理机制,DBS的适用情况、疗效、不良反应及脑靶点展开述评,以期为DBS在PD治疗中的应用提供更全面的认识,推动该领域的进一步发展。

Parkinson's disease (PD) is a progressive neurodegenerative disorder with both motor and non-motor symptoms. Deep brain stimulation (DBS) is applicable to advanced PD patients whose symptoms cannot be adequately controlled by medication and whose quality of life cannot be well guaranteed,as well as to those who have severe adverse reactions(such as dyskinesia)due to dopaminergic drugs. DBS can provide personalized treatment according to the specific symptoms of patients,and the treatment is carried out for different nodes in the basal ganglia-thalamus pathway,and these nodes play a mediating role in various symptoms of the disease. DBS of the ventral intermediate nucleus of the thalamus is the most effective in controlling tremors,DBS of the globus pallidus is significantly effective in controlling rigidity and dyskinesia,while DBS of the subthalamic nucleus can simultaneously treat tremors,bradykinesia,rigidity and dyskinesia,and can reduce the amount of medication used by patients,and is also the preferred treatment goal in the late stage of the disease. DBS has a long-term therapeutic effect on limb symptoms,but as the disease progresses,the response of non-dopaminergic axial features to DBS will gradually deteriorate.The DBS treatment of PD is highly specialized and requires a multidisciplinary team composed of movement disorder neurologists,functional neurosurgeons,professional DBS programmers,and neuropsychologists to screen and follow up patients. This article reviews the pathological mechanism,the applicability,efficacy,adverse reactions,and brain targets of DBS,in order to provide a more comprehensive understanding of the application of DBS in the treatment of PD and promote the further development in this field.

[1]
Katz M,Luciano MS,Carlson K,et al. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease[J].Ann Neurol,2015,77(4):710-719.DOI:10.1002/ana.24374.
[2]
Alexander GE,DeLong MR,Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex[J].Annu Rev Neurosci,1986,9:357-381.DOI:10.1146/annurev.ne.09.030186.002041.
[3]
Obeso JA,Rodríguez - Oroz MC,Benitez - Temino B,et al.Functional organization of the basal ganglia:therapeutic implications for Parkinson's disease[J]. Mov Disord,2008,23 Suppl 3:S548-S559.DOI:10.1002/mds.22062.
[4]
Lang AE,Lozano AM.Parkinson's disease.First of two parts[J].N Engl J Med,1998,339(15):1044-1053.DOI:10.1056/NEJM1998 10083391506.
[5]
Mirzadeh Z,Chapple K,Lambert M,et al. Parkinson's disease outcomes after intraoperative CT -guided“asleep”deep brain stimulation in the globus pallidus internus[J]. J Neurosurg,2016,124(4):902-907.DOI:10.3171/2015.4.Jns1550.
[6]
Ho AL,Ali R,Connolly ID,et al.Awake versus asleep deep brain stimulation for Parkinson's disease:a critical comparison and meta-analysis[J].J Neurol Neurosurg Psychiatry,2018,89(7):687-691.DOI:10.1136/jnnp-2016-314500.
[7]
Bronstein JM,Tagliati M,Alterman RL,et al. Deep brain stimulation for Parkinson disease:an expert consensus and review of key issues[J]. Arch Neurol,2011,68(2):165. DOI:10.1001/archneurol.2010.260.
[8]
Foltynie T,Hariz MI.Surgical management of Parkinson's disease[J]. Expert Rev Neurother,2010,10(6):903-914. DOI:10.1586/ern.10.68.
[9]
Charles PD,Van Blercom N,Krack P,et al.Predictors of effective bilateral subthalamic nucleus stimulation for PD[J]. Neurology,2002,59(6):932-934.DOI:10.1212/wnl.59.6.932.
[10]
Hariz MI,Johansson F,Shamsgovara P,et al. Bilateral subthalamic nucleus stimulation in a Parkinsonian patient with preoperative deficits in speech and cognition:persistent improvement in mobility but increased dependency:a case study[J]. Mov Disord,2000,15(1):136-139. DOI:10.1002/1531-8257(200001)15:1<136::aid-mds1021>3.0.co;2-5.
[11]
Bucur M,Papagno C. Deep brain stimulation in Parkinson disease:a meta-analysis of the long-term neuropsychological outcomes[J]. Neuropsychol Rev,2023,33(2):307-346. DOI:10.1007/s11065-022-09540-9.
[12]
Tripoliti E,Limousin P,Foltynie T,et al. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson 's disease[J]. Mov Disord,2014,29(4):532-538.DOI:10.1002/mds.25816.
[13]
Krishnan S,Shetty K,Puthanveedu DK,et al. Apraxia of lid opening in subthalamic nucleus deep brain stimulation for Parkinson ' s disease - frequency,risk factors and response to treatment[J]. Mov Disord Clin Pract,2021,8(4):587-593. DOI:10.1002/mdc3.13206.
[14]
Sierra M,Carnicella S,Strafella AP,et al. Apathy and impulse control disorders:yin& yang of dopamine dependent behaviors[J].J Parkinsons Dis,2015,5(3):625-636.DOI:10.3233/jpd-150535.
[15]
Ardouin C,Chéreau I,Llorca PM,et al.Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease[J]. Rev Neurol(Paris),2009,165(11):845-856.DOI:10.1016/j.neurol.2009.06.003.
[16]
Amstutz D,Paschen S,Lachenmayer ML,et al. Management of impulse control disorders with subthalamic nucleus deep brain stimulation in Parkinson's disease[J]. CNS Neurol Disord Drug Targets,2020,19(8):611-617. DOI:10.2174/1871527319666200 720105553.
[17]
Voon V,Krack P,Lang AE,et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease[J]. Brain,2008,131(Pt 10):2720-2728. DOI:10.1093/brain/awn214.
[18]
Zoon TJC,van Rooijen G,Balm G,et al. Apathy induced by subthalamic nucleus deep brain stimulation in Parkinson's disease:a meta-analysis[J]. Mov Disord,2021,36(2):317-326. DOI:10.1002/mds.28390.
[19]
Bourilhon J,Mullie Y,Olivier C,et al. Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease:cross-over single-blinded study and long-term follow-up[J]. Parkinsonism Relat Disord,2022,96:13-17.DOI:10.1016/j.parkreldis.2022.01.010.
[20]
Barnikol TT,Pawelczyk NB,Barnikol UB,et al. Changes in apraxia after deep brain stimulation of the nucleus basalis Meynert in a patient with Parkinson dementia syndrome[J]. Mov Disord,2010,25(10):1519-1520.DOI:10.1002/mds.23141.
[21]
Gratwicke J,Zrinzo L,Kahan J,et al. Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia:a randomized clinical trial[J]. JAMA Neurol,2018,75(2):169-178.DOI:10.1001/jamaneurol.2017.3762.
[22]
Vedam-Mai V,Deisseroth K,Giordano J,et al. Proceedings of the eighth annual deep brain stimulation think tank:advances in optogenetics,ethical issues affecting DBS research,neuromodulatory approaches for depression,adaptive neurostimulation,and emerging DBS technologies[J].Front Hum Neurosci,2021,15:644593.DOI:10.3389/fnhum.2021.644593.
[23]
Binder DK,Shah BB,Elias WJ. Focused ultrasound and other lesioning in the treatment of tremor[J]. J Neurol Sci,2022,435:120193.DOI:10.1016/j.jns.2022.120193.
[24]
Milekovic T,Moraud EM,Macellari N,et al. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease[J].Nat Med,2023,29(11):2854-2865.DOI:10.1038/s41591-023-02584-1.
[1] 曾倩, 徐朝阳, 张丽芳. 帕金森病步态分析的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 235-238.
[2] 李红星, 彭肖肖, 张凯, 刘贻哲, 王瀚, 李超, 杜祎祎, 宗强. 双靶点脑深部电刺激术治疗原发性震颤的疗效分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 225-229.
[3] 甄雪克, 田宏, 许骏, 徐晓利, 张黎, 于炎冰. 手术机器人辅助脑深部电刺激术治疗不随意运动型脑性瘫痪二例报道并文献复习[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 124-126.
[4] 罗彦妮, 陈浪, 莫励华, 韦宁, 罗纯, 黎彬如. 血清CysC、Hcy水平与帕金森病伴发脑白质病变的关系[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 340-345.
[5] 金刚, 李英真, 施维, 李博. 帕金森病在病理生理学中的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 315-319.
[6] 党圆圆, 赵虎林. 机器人辅助小脑齿状核脑深部电刺激植入术[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 320-320.
[7] 徐武, 姜成荣, 种玉龙, 梁维邦. 脑深部电刺激术治疗梅杰综合征的两年疗效分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2022, 12(06): 365-369.
[8] 郑丽华, 钱一菁, 黄崇甄, 周春娜. 山茱萸环烯醚萜苷改善6-OHDA诱导帕金森病细胞模型的损伤[J/OL]. 中华脑科疾病与康复杂志(电子版), 2022, 12(06): 324-331.
[9] 陈普建, 张璟, 陈芬, 陈怡伟, 余蓓蓓, 周春英. 双侧丘脑底核交叉电脉冲脑深部电刺激对帕金森病步态障碍的疗效观察[J/OL]. 中华脑科疾病与康复杂志(电子版), 2022, 12(05): 298-301.
[10] 李玺琳, 章邱东. 帕金森病患者胃肠功能障碍特点及其风险因素分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(03): 145-149.
[11] 耿磊, 张照婷, 许磊, 黄海, 孙毅, 杨伏猛, 徐凯, 胡春峰. 帕金森病前驱期基底神经节环路磁共振弥散张量成像的应用研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(09): 995-1003.
[12] 杨团峰, 孟雪, 王艳香, 卢葭, 孔德生, 赵元立, 刘献增. 男性帕金森病患者球海绵体肌反射初步研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(01): 28-32.
[13] 谢艾伦, 郑冬燕, 蔡紫薇, 卢仁建, 彭永明, 张贺, 陈家隆. 鱼藤酮通过降低线粒体钙离子单向转运体蛋白表达促进多巴胺能神经元铁死亡[J/OL]. 中华临床实验室管理电子杂志, 2023, 11(02): 71-78.
[14] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J/OL]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15] 韩远远, 于紫涵, 杨玲, 程弘禹, 宋春杰. C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值对老年帕金森病的诊断价值[J/OL]. 中华老年病研究电子杂志, 2023, 10(01): 14-19.
阅读次数
全文


摘要